Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
about
Identification and characterization of proteins that selectively interact with isoforms of the mRNA binding protein AUF1 (hnRNP D)Myosin heavy chain gene expression in human heart failureHistone deacetylase signaling in cardioprotectionA polymorphism in the beta1 adrenergic receptor is associated with resting heart ratePreservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarctionDecreased expression of beta1- and beta2-adrenoceptors in human diabetic atrial appendageChronic alcohol consumption from adolescence-to-adulthood in mice--hypothalamic gene expression changes in the dilated cardiomyopathy signaling pathway.Folding of A+U-rich RNA elements modulates AUF1 binding. Potential roles in regulation of mRNA turnover.Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction.RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism.Purification of cardiac myocytes from human heart biopsies for gene expression analysis.Molecular remodeling of ion channels, exchangers and pumps in atrial and ventricular myocytes in ischemic cardiomyopathy.Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.β-Adrenergic receptor subtype signaling in heart: from bench to bedside.Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene deliveryCentral sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature.Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathyG protein coupled receptor kinases as therapeutic targets in cardiovascular disease.Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heartTemporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the β1-adrenergic receptor.Molecular determinants of altered contractility in heart failure.New Isoform of Cardiac Myosin Light Chain Kinase and the Role of Cardiac Myosin Phosphorylation in α1-Adrenoceptor Mediated Inotropic Response.Clinical Evaluation of Heart Failure: Agreement among Tests.T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure.Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.The role of adrenergic receptor polymorphisms in heart failure.Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.Remodeling of calcium handling in human heart failure.β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytesPotentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytesChanges in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.Three basic residues of intracellular loop 3 of the beta-1 adrenergic receptor are required for golgin-160-dependent trafficking.Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.A piece of the human heart: variance of protein phosphorylation in left ventricular samples from end-stage primary cardiomyopathy patients.Adrenergic signaling polymorphisms and their impact on cardiovascular disease.Cardiorenal syndrome: pathophysiology and potential targets for clinical management.Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway.
P2860
Q24299254-171691D7-F63B-4B71-94FE-05B8EC4D49ABQ24561412-2083408F-D682-4A81-9A72-F475620BAC4FQ24568237-A692A867-C37D-41BD-9500-58972283C824Q24613583-1D210A94-4890-4BE6-982A-DCC746EADF95Q24656335-697553CD-F7D9-451D-B9F6-0FB1D9D31DF9Q24802547-82B8ED9D-C4B1-4615-8AD2-E7ED820015BEQ30578491-6DA938C3-9674-434A-973E-D5DD8F19C63FQ31743223-AFCAB6DC-C3F5-4D67-8F88-F31E2E757120Q31940102-65DD11D0-61B2-428F-897A-9686E54C2252Q33168540-0AD889FA-C6F6-4E2A-93DF-425746435132Q33484098-CA190DC1-2FD3-43CA-B1F3-0666C42EDD3DQ33525464-4A781822-27B8-4861-A75F-6A0239947FDAQ33807046-E49ED638-B3E8-4BE1-B5B3-CD494DE91DE1Q33828730-52B3950F-212E-4C69-90EA-D33D10819A0EQ33853399-78B69235-860B-4FA2-B302-7489BB2EB535Q34661152-E1DFF3C8-6AA0-4C9F-8301-3554BB284C30Q34974147-DF0ADFC6-A2A8-4FE7-8605-9AAB1336A4DFQ35135090-E74C6797-8899-4FE5-8B33-260D540374A6Q35553783-F335C2C6-E97F-4055-98EB-DE46F3C33A18Q35601437-15EE4122-04F9-4B09-9623-A3326F6FB1BBQ35791489-A8F76800-73B8-41EB-A1E8-2AE8F094E39BQ35825781-0F03957D-EFE8-49BD-B120-29C0C056192DQ36107124-07A31476-6E7F-4DC7-BB5D-D4780695C52BQ36123708-50EBFFE6-ADEF-4EF4-8EF0-4D444504B946Q36342091-2B5248A4-C4EA-4D4C-9009-35418C06788DQ36629879-2D115D52-3812-4EEC-9891-D5330F74911DQ36848480-9B8DF030-9502-4801-B0FC-0BC870AFCCC7Q37038822-5A540C51-D116-4FD6-ADF2-89C2F25E0CFEQ37088473-5457C115-6569-4D63-96FE-B4E9E1EC4C94Q37102508-B26A0961-764B-4A66-A0E1-8BC7B5083E3AQ37126029-67AA98CD-B299-4351-81C6-E4B66DF61A42Q37362466-C1BAEEAB-7266-4860-B12E-A4D25007BF43Q37374337-F82EE873-4917-4346-BE7A-EB985E6704CAQ37379383-D2F7B363-E3B5-4D43-B981-5867653C423DQ37645355-A12216AF-94D8-4EA7-AC64-D1AA5F656E06Q37692816-57C0566E-4CA4-43EE-A8BE-7D2C977CF149Q37705107-22DA768A-8F7E-42C7-8C84-7E4FEB64E483Q37776088-2E3BEB3D-4B72-4229-AA48-4C55E7FBF3DFQ38068097-6A9852B1-B43C-461A-B44F-2749CC84F811Q38359236-3F6A572E-F998-426A-8484-963C386E3D09
P2860
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
@ast
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
@en
type
label
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
@ast
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
@en
prefLabel
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
@ast
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
@en
P2093
P2860
P356
P1476
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
@en
P2093
A M Feldman
M R Bristow
M V Raynolds
R Rasmussen
W A Minobe
P2860
P304
P356
10.1172/JCI116891
P407
P577
1993-12-01T00:00:00Z